Regulus: Q1 Earnings Snapshot
By AP News
Published - May 11, 2023, 04:21 PM ET
Last Updated - Jun 21, 2023, 08:25 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $7.1 million in its first quarter.
The San Diego-based company said it had a loss of 42 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a RGLS">Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS
